Weight loss pills have been around for decades, but many were deemed unsafe by the FDA. Learn more about today’s ...

Meanwhile, as people spend more time indoors during winter months, Cleveland Clinic experts are urging residents to check ...

Patients also have to deal with changes to their health insurance at the start of a new year, and more employers have ...

Weight gain is common in women during perimenopause and after menopause, but the physical changes underlying it start much ...

While GLP-1s boast impressive weight loss results, making one mistake could result in the pounds coming right back on, ...

Weight fluctuation happens daily, week to week, or month to month. Learn about causes and when to see a healthcare provider about weight changes.

GLP-1 weight-loss pills appear to be just as effective as injections, with clinical trials showing similar average weight ...

Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection.

The FDA-approved weight loss drug offers an oral alternative to invasive injections with similar effectiveness.

Dec. 30, 2025 – updated Jan. 5, 2026 – Injectable GLP-1 drugs have transformed obesity treatment – and now they're going oral. "It's good to have more options for patients with obesity," said Melanie ...

LONDON, Dec 29 (Reuters) - Ask executives in the healthcare industry about the future market for weight-loss drugs and the analogies are telling: monthly GLP-1 medicine subscriptions like a streaming ...

The recent U.S. Food and Drug Administration (FDA) approval of Novo Nordisk’s NVO oral obesity pill, Wegovy, marks a significant turning point in the fiercely competitive weight-loss drug market. This ...